Sodium Chloride Injection, Solution
Product Images NDC 65219-220

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sodium Chloride (NDC 65219-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sod0s 0002 01

FDA Label Image

Sod0s 0002 02

FDA Label Image

Sod0s 0002 03

Label for 0.9% Sodium Chloride Injection, USP, 50 mL intravenous solution by Fresenius Kabi USA, LLC. Contains 900 mg sodium chloride per 100 mL in water for injection, with sodium and chloride electrolytes at 154 mEq/L each. The label includes storage instructions, warnings about additives, and manufacturer information.*

FDA Label Image

Sod0s 0002 04

Label for 0.9% Sodium Chloride Injection, USP solution by Fresenius Kabi USA, LLC. The product is packaged as 50 mL vials in a quantity of 60, indicated for intravenous use. Storage instructions specify 20° to 25°C (68° to 77°F) and protection from freezing. The label includes barcodes, lot number, expiration date placeholder, and manufacturing details indicating origin in Norway.*

FDA Label Image

Sod0s 0002 05

Label for 0.9% Sodium Chloride Injection, USP, 100 mL intravenous solution by Fresenius Kabi USA, LLC. The label shows the concentration as 9 mg/mL with electrolyte content per 1,000 mL listed, including sodium and chloride at 154 mEq each. It includes storage instructions, a barcode, and manufacturing details indicating the product is made in Norway.*

FDA Label Image

Sod0s 0002 06

Label for 0.9% Sodium Chloride Injection, USP by Fresenius Kabi USA, LLC, containing 100 mL per unit, packaged as a quantity of 50. The label indicates storage at 20° to 25°C and protection from freezing, with the product made in Norway and manufactured for Fresenius Kabi in Lake Zurich, IL. The label also features barcodes and batch information.*

FDA Label Image

Sod0s 0002 07

Label for Freeflex 0.9% Sodium Chloride Injection, USP, 250 mL intravenous solution. Each 100 mL contains 900 mg sodium chloride. Electrolytes and pH values noted, with storage instructions at 20° to 25°C. Manufactured for Fresenius Kabi USA, LLC, made in Germany. Barcode and lot/expiration placeholders included.*

FDA Label Image

Sod0s 0002 08

The label for 0.9% Sodium Chloride Injection, USP, 250 mL vials in a 30-count package, branded as freeflex+, manufactured for Fresenius Kabi USA, LLC. The label shows storage instructions, a barcode, and manufacturing location in Lake Zurich, Illinois, made in Germany.*

FDA Label Image

Sod0s 0002 09

Label for 0.9% Sodium Chloride Injection, USP, 500 mL intravenous solution by Fresenius Kabi USA, LLC. The label includes concentration details (900 mg per 100 mL), electrolytes content, storage instructions, and manufacturer information including a barcode and lot/expiration placeholders.*

FDA Label Image

Sod0s 0002 10

Label for 0.9% Sodium Chloride Injection, USP by Fresenius Kabi USA, LLC. The label indicates a package of 500 mL x 20 units, with storage instructions at 20° to 25°C (68° to 77°F) and protection from freezing. It includes the NDC code 65219-224-50 and states the product is made in Germany for Fresenius Kabi in Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.